Log In
BCIQ
Print this Print this
 

IW-9179

  Manage Alerts
Collapse Summary General Information
Company Ironwood Pharmaceuticals Inc.
DescriptionGuanylate cyclase C (GCC; GUCY2C) agonist
Molecular Target Guanylate cyclase C (GCC) (GUCY2C)
Mechanism of ActionGuanylate cyclase C agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDyspepsia
Indication DetailsTreat functional dyspepsia (FD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today